Navigation Links
New Osteoarthritis Research Grant Program Initiated by AOSSM and Genzyme Biosurgery
Date:2/25/2010

The American Orthopaedic Society for Sports Medicine (AOSSM), in partnership with Genzyme Biosurgery, is pleased to announce a new research grant program to fund investigations related to early osteoarthritis (OA) and/or prevention of OA progression.

Rosemont, IL (Vocus) February 25, 2010 -- The American Orthopaedic Society for Sports Medicine (AOSSM), in partnership with Genzyme Biosurgery, is pleased to announce a new research grant program to fund investigations related to early osteoarthritis (OA) and/or prevention of OA progression. This grant program reflects a growing recognition of the importance of osteoarthritis within the sports medicine and orthopaedics world. The program is an outgrowth of the Society’s conference on post-joint injury OA held in December 2008 and it underscores Genzyme’s long-standing commitment to osteoarthritis research and therapy.

“Genzyme is very pleased to continue our ongoing support of the AOSSM through this important research award. Our hope is that by providing greater opportunities to the orthopaedic sports medicine research community, more innovative ideas will be generated to help improve the lives of patients with this disabling disease,” said Jeffrey L Kraines, MD, Head, Medical Affairs and Senior Medical Director, Genzyme Biosurgery.

Two separate grants will be offered. One will provide an annual $50,000 grant for a clinical research study that is renewable for three years ($150,000 total), subject to a progress review. The second will be a one-time award of $50,000 to support a lab/basic science project to different investigators over a successive three year time period.

Proposed studies need not relate specifically to sports injuries and should also have broad applicability to OA in the general population. Projects involving viscosupplementation will not be considered for either grant. Applications will be reviewed for their potential impact on the field, the quality of study approach, and the ability of the investigator and site(s) to conduct and complete the proposed research.

The Principal Investigator on all applications must be an AOSSM member who has completed his or her training. It is expected that grantees will submit the results from their funded study to AOSSM for podium presentation and to the American Journal for Sports Medicine (AJSM) for publication. The submission deadline for both the clinical and basic science grants is August 1st, 2010. Award notices will be made on or after October 15th with a start date of January 1, 2011. Inquires can be directed to Bart Mann, AOSSM Director of Research (bart(at)aossm(dot)org). Additional information and application materials can be obtained on the AOSSM website at http://www.sportsmed.org/tabs/research/aossmgrants.aspx.

The American Orthopaedic Society for Sports Medicine (AOSSM) is a world leader in sports medicine education, research, communication and fellowship, and includes national and international orthopaedic sports medicine leaders. The Society works closely with many other sports medicine specialists, including athletic trainers, physical therapists, family physicians, and others to improve the identification, prevention, treatment, and rehabilitation of sports injuries. For more information, please contact AOSSM Director of Communications, Lisa Weisenberger, at 847/292-4900. Additional information and press releases can be viewed in the newsroom on AOSSM’s Web site at www.sportsmed.org. For more information about Genzyme Biosurgery, visit www.genzyme.com

# # #

Read the full story at http://www.prweb.com/releases/osteoarthritis/sports_medicine/prweb3650094.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Using coxibs and NSAIDs to treat osteoarthritis
2. Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
3. New insights into inflammation in osteoarthritis
4. Study shows pine bark naturally reduces osteoarthritis knee pain
5. Orthopedic Surgeon Contributes Knowledge on Research and Treatment in Weekly Blogs on MyOsteoarthritisCentral.com
6. The risk of osteoarthritis and index to ring finger length ratio
7. Genes Linked to Height Also Tied to Osteoarthritis Risk
8. Gender Bias at Play in Treatment of Knee Osteoarthritis
9. Gender bias may affect care of people with osteoarthritis, study finds
10. Study Shows Pine Bark Naturally Reduces Osteoarthritis
11. Study shows pine bark naturally reduces osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Osteoarthritis Research Grant Program Initiated by AOSSM and Genzyme Biosurgery 
(Date:5/2/2016)... ... May 02, 2016 , ... Beanfields, PBC, makers ... partnering with college students at University of Colorado in Boulder to create new ... campaigns class in the School of Journalism, who selected Beanfields as the brand ...
(Date:5/2/2016)... ... May 02, 2016 , ... In honor of National Physical Fitness ... to people who share their fitness journey on social media. , The foot ... will award a $100 product voucher each week during May to one winner. , ...
(Date:5/2/2016)... ... , ... East Los Angeles dentist , Dr. Ramin Assili, is now ... receive any dental extraction treatment for $40 off the regular price. This promotion cannot ... lower price, patients can more easily afford extractions to eliminate teeth that are damaged ...
(Date:5/2/2016)... County, CA (PRWEB) , ... May 02, 2016 , ... ... now linking dental health and cognitive decline. According to the research, which was published ... have some degree of cognitive decline, and about 5.4 million Americans have Alzheimer’s disease. ...
(Date:5/2/2016)... ... 02, 2016 , ... Pregnancy Awareness Month offers a great time to get ... “If you are ready to have a baby, it’s best to get started before ... is your Personal Conception & Pregnancy Organizer, written for women who plan on becoming ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
(Date:4/28/2016)... , April 28, 2016 ... development of innovative peptide and gene-based immunotherapeutics and vaccines for ... will be presenting at the 3rd Annual Growth Capital ... 5 th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... am on Wednesday, May 4 th by Dr. ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
Breaking Medicine Technology: